1. Home
  2. EIG vs OCUL Comparison

EIG vs OCUL Comparison

Compare EIG & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EIG
  • OCUL
  • Stock Information
  • Founded
  • EIG 2000
  • OCUL 2006
  • Country
  • EIG United States
  • OCUL United States
  • Employees
  • EIG N/A
  • OCUL N/A
  • Industry
  • EIG Property-Casualty Insurers
  • OCUL Biotechnology: Pharmaceutical Preparations
  • Sector
  • EIG Finance
  • OCUL Health Care
  • Exchange
  • EIG Nasdaq
  • OCUL Nasdaq
  • Market Cap
  • EIG 1.2B
  • OCUL 957.3M
  • IPO Year
  • EIG 2007
  • OCUL 2014
  • Fundamental
  • Price
  • EIG $48.46
  • OCUL $7.31
  • Analyst Decision
  • EIG Strong Buy
  • OCUL Strong Buy
  • Analyst Count
  • EIG 1
  • OCUL 10
  • Target Price
  • EIG $58.00
  • OCUL $16.22
  • AVG Volume (30 Days)
  • EIG 206.6K
  • OCUL 1.9M
  • Earning Date
  • EIG 05-01-2025
  • OCUL 05-06-2025
  • Dividend Yield
  • EIG 2.48%
  • OCUL N/A
  • EPS Growth
  • EIG 5.84
  • OCUL N/A
  • EPS
  • EIG 4.71
  • OCUL N/A
  • Revenue
  • EIG $880,700,000.00
  • OCUL $63,723,000.00
  • Revenue This Year
  • EIG $1.01
  • OCUL $13.32
  • Revenue Next Year
  • EIG $2.80
  • OCUL $13.13
  • P/E Ratio
  • EIG $10.26
  • OCUL N/A
  • Revenue Growth
  • EIG 3.50
  • OCUL 9.03
  • 52 Week Low
  • EIG $38.67
  • OCUL $4.06
  • 52 Week High
  • EIG $54.44
  • OCUL $11.78
  • Technical
  • Relative Strength Index (RSI)
  • EIG 46.45
  • OCUL 51.39
  • Support Level
  • EIG $46.69
  • OCUL $6.94
  • Resistance Level
  • EIG $49.15
  • OCUL $7.83
  • Average True Range (ATR)
  • EIG 1.47
  • OCUL 0.72
  • MACD
  • EIG -0.05
  • OCUL 0.07
  • Stochastic Oscillator
  • EIG 52.06
  • OCUL 74.57

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: